Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Oxcarbazepine NDC 51991-293 by Breckenridge Pharmaceutical, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - oxcarbazepine 01

Chemical Structure - oxcarbazepine 01

Figure 1 - oxcarbazepine 02

Figure 1 - oxcarbazepine 02

Figure 2 - oxcarbazepine 03

Figure 2 - oxcarbazepine 03

The given text provides the seizure rate and the p-value obtained from a log-rank test. The graph shows the number of days from the 1st dose to the 1st seizure for two treatment groups: Oxcarbazepine and Placebo. Therefore, it can be inferred that the provided information is related to a study on the effectiveness of Oxcarbazepine in preventing seizures.*

Figure 3 - oxcarbazepine 04

Figure 3 - oxcarbazepine 04

Figure 4 - oxcarbazepine 05

Figure 4 - oxcarbazepine 05

The text appears to be a plot or a figure showing the time to exit in days for two treatment groups - HIGH and LOW. There is also information about the p-value of the log-rank test. It is not possible to provide a more specific description without further context.*

Principal Display Panel - 150 mg Bottle Label - oxcarbazepine 06

Principal Display Panel - 150 mg Bottle Label - oxcarbazepine 06

This is a medication that comes in the form of a film-coated tablet containing 150mg of oxcarbazepine per tablet. The dosage and full product information can be found in the insert. The tablets contain FD&C Yellow No.5 as a color additive and must be kept in a tight container, away from children. Recommended storage temperature is between 20-25°C with permitted excursions to 15-30°C. The medication should be dispensed with a medication guide to each patient. The manufacturer is LGM Pharma Solutions LLC and the distributor is Breckenridge Pharmaceutical Inc. NDC number is 51991-292-01.*

Principal Display Panel - 300 mg Bottle Label - oxcarbazepine 07

Principal Display Panel - 300 mg Bottle Label - oxcarbazepine 07

Each film-coated tablet of oxcarbazepine contains 300mg and is distributed by Breckenridge Pharmaceutical, Inc. The tablets may contain FD&C Yellow No. 5 (tartrazine) and should be stored in a tight container between 59-86°F. More information about dosage and usage can be found in the insert provided. This medication should be kept out of reach of children. Manufactured by LGM Pharma Solutions, LLC.*

Principal Display Panel - 600 mg Bottle Label - oxcarbazepine 08

Principal Display Panel - 600 mg Bottle Label - oxcarbazepine 08

Each tablet contains 600mg of oxcarbazepine. The dosage and complete product information can be found in the insert. It contains a color additive FDAC Yellow No. 5 (artrazine). The tablet should be stored at 20°-25°C (77°F) with excursions permitted to 15°C-30°C (56°F-86°F). Dispense in tight container (USP). Distributed by Breckenridge Pharmaceutical, Inc. Berlin, CT 06037. It should be kept out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.